BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1285251)

  • 21. The protective role of a natural inhibitor in the fluorescent location of cells possessing a latent form of cell surface protease.
    Steven FS; Williams LA
    J Enzyme Inhib; 1990; 3(4):317-22. PubMed ID: 1690794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoic acid inhibition of a tumour protease immobilised on cell surfaces and in free solution.
    Anees M; Steven FS
    J Enzyme Inhib; 1994; 8(1):51-9. PubMed ID: 7539069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of the antitumor drug 9-aminoacridine with guanidinobenzoatase studied by spectroscopic methods: a possible tumor marker probe based on the fluorescence exciplex emission.
    Murza A; Sánchez-Cortés S; García-Ramos JV; Guisan JM; Alfonso C; Rivas G
    Biochemistry; 2000 Aug; 39(34):10557-65. PubMed ID: 10956047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of a tumour protease with 3,4-dichloroisocoumarin, pentamidine-isethionate and guanidino derivatives.
    Anees M; Steven FS
    J Enzyme Inhib; 1994; 8(3):213-21. PubMed ID: 7539490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporary competitive inhibition of a tumour cell surface protease as a protective mechanism in the preparation of the membrane bound native enzyme in the presence of excess cytoplasmic inhibitors.
    Steven FS; Griffin MM; Maier H
    J Enzyme Inhib; 1991; 5(1):77-85. PubMed ID: 1669439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescent location of malignant cells in smears obtained from sputum.
    Steven FS; Payne PW; Palcic B
    Anticancer Res; 1994; 14(5A):2021-4. PubMed ID: 7847845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dansyl fluoride, a fluorescent inhibitor for the location of tumour cells in human tissues.
    Anees M; Benbow EW
    J Enzyme Inhib; 1996; 10(3):195-201. PubMed ID: 8835945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A protein inhibitor, extracted from Hela cells, which recognises a cell surface protease on preneoplastic cells obtained from cervical smears.
    Steven FS; Johnson J; Eason P
    Anticancer Res; 1993; 13(4):1059-61. PubMed ID: 8352525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for inhibitors of the cell surface protease guanidinobenzoatase.
    Steven FS; Griffin MM; Wong TL; Itzhaki S
    J Enzyme Inhib; 1986; 1(2):127-37. PubMed ID: 3508910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of a protease associated with tumour cells and the probable mechanism of regulation of this interaction in vivo.
    Steven FS; Maier H; Arndt J
    J Enzyme Inhib; 1989; 3(2):145-57. PubMed ID: 2489235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting adriamycin to tumour cells by means of an affinity ligand; a model system for drug delivery.
    Steven FS; Griffin MM; Williams LA; Ali H; Maier H
    Anticancer Res; 1989; 9(1):247-53. PubMed ID: 2705751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface-enhanced Raman and steady fluorescence study of interaction between antitumoral drug 9-aminoacridine and trypsin-like protease related to metastasis processes, guanidinobenzoatase.
    Murza A; Sánchez-Cortés S; García-Ramos JV
    Biopolymers; 2001; 62(2):85-94. PubMed ID: 11288057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of inhibitors in the fluorescent staining of benign naevus and malignant melanoma cells with 9-amino acridine and acridine orange.
    Steven FS; Suresh U; Wong TL; Griffin MM
    J Enzyme Inhib; 1987; 1(4):275-87. PubMed ID: 3508914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid technique for the fluorescent location of pleomorphic adenoma cells in frozen sections of human salivary glands.
    Steven FS; Griffin MM; Maier H; Born IA
    Anticancer Res; 1990; 10(1):91-6. PubMed ID: 2159255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of the proteolytic enzyme guanidinobenzoatase in human basal cell carcinoma.
    Steven FS; Maier H; Born A; Weidauer H
    ORL J Otorhinolaryngol Relat Spec; 1989; 51(6):360-4. PubMed ID: 2480560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective fluorescent location of epithelial cells which possess the proteinase guanidinobenzoatase in cervical smears.
    Steven FS; Johnson J
    Biochem Soc Trans; 1990 Aug; 18(4):632. PubMed ID: 2125943
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of guanidinobenzoatase: evidence for multiple forms of this protease on different tumour cells.
    Steven FS; Griffin MM; Freemont AJ; Johnson J
    J Enzyme Inhib; 1988; 2(2):117-27. PubMed ID: 3236068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescent inhibitors of a cell surface protease used to locate leukaemia cells in kidney sections.
    Steven FS; Griffin MM; Wong TL; Jackson H; Barnett F
    J Enzyme Inhib; 1987; 1(3):203-13. PubMed ID: 3334245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The status of the surface enzyme guanidinobenzoatase on mature epithelial cells in sputum cell monolayers.
    Steven FS; Payne PW; Palcic B
    Anticancer Res; 1993; 13(2):311-5. PubMed ID: 8517644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of an isoenzymic form of a cell surface protease expressed in human colonic tumour cells but not in normal colonic cells.
    Steven FS; Talbot IC
    Biochem Soc Trans; 1991 Apr; 19(2):236S. PubMed ID: 1889603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.